Replies to post #1639 on Actinium Pharmaceuticals Inc (ATNM)

[Peron]

TOP NEWS out today!!

Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO Annual Meeting.

https://web.tmxmoney.com/article.php?newsid=7481297048893155&qm_symbol=ATNM:US